Skip to Main Content

Paper Details

An inflammatory cytokine signature predicts COVID-19 severity and survival.
Nat Med
1580
2020
COVID-19, IL, IL-6, IL-8, Patients, SARS, SARS-CoV-2, TNF-, TNF- serum, coronavirus disease 2019, hyper-inflammatory, hypoxia, patient, patients, serum, serum interleukin (IL)-6, severe acute respiratory syndrome coronavirus, tumor necrosis factor (TNF)-
Author NameAffiliation
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzePrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzePrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai
Noam D BeckmannIcahn School of Medicine at Mount Sinai
Adeeb RahmanIcahn School of Medicine at Mount Sinai
Adeeb RahmanIcahn School of Medicine at Mount Sinai
Adeeb RahmanTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Adeeb RahmanPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Patricia KovatchIcahn School of Medicine at Mount Sinai
Patricia KovatchIcahn School of Medicine at Mount Sinai
Eric E SchadtIcahn School of Medicine at Mount Sinai
Eric E SchadtIcahn School of Medicine at Mount Sinai
Sundar JagannathIcahn School of Medicine at Mount Sinai
Madhu MazumdarInstitute for Health Care Delivery Science, Icahn School of Medicine at Mount Sinai
Madhu MazumdarIcahn School of Medicine at Mount Sinai
Madhu MazumdarIcahn School of Medicine at Mount Sinai
Alexander W CharneyIcahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
Sacha GnjaticIcahn School of Medicine at Mount Sinai
  • 1 - 44

Datasets

Release 1.2